Gonzalez-Angulo AM - Search Results

1

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer.

Gonzalez-Angulo AM, Hennessy BT, Meric-Bernstam F, Sahin A, Liu W, Ju Z, Carey MS, Myhre S, Speers C, Deng L, Broaddus R, Lluch A, Aparicio S, Brown P, Pusztai L, Symmans WF, Alsner J, Overgaard J, Borresen-Dale AL, Hortobagyi GN, Coombes KR, Mills GB. Gonzalez-Angulo AM, et al. Clin Proteomics. 2011 Jul 8;8(1):11. doi: 10.1186/1559-0275-8-11. Clin Proteomics. 2011. PMID: 21906370 Free PMC article.

2

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.

Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB. Hennessy BT, et al. Clin Proteomics. 2010 Dec;6(4):129-51. doi: 10.1007/s12014-010-9055-y. Clin Proteomics. 2010. PMID: 21691416 Free PMC article.

3

Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma.

Gonzalez-Angulo AM, Krishnamurthy S, Yamamura Y, Broglio KR, Pusztai L, Buzdar AU, Hortobagyi GN, Esteva FJ. Gonzalez-Angulo AM, et al. Cancer. 2004 Jul 15;101(2):258-63. doi: 10.1002/cncr.20348. Cancer. 2004. PMID: 15241821 Free article.

4

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.

Rouzier R, Pusztai L, Delaloge S, Gonzalez-Angulo AM, Andre F, Hess KR, Buzdar AU, Garbay JR, Spielmann M, Mathieu MC, Symmans WF, Wagner P, Atallah D, Valero V, Berry DA, Hortobagyi GN. Rouzier R, et al. J Clin Oncol. 2005 Nov 20;23(33):8331-9. doi: 10.1200/JCO.2005.01.2898. J Clin Oncol. 2005. PMID: 16293864

5

Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.

Hanrahan EO, Valero V, Gonzalez-Angulo AM, Hortobagyi GN. Hanrahan EO, et al. J Clin Oncol. 2006 May 1;24(13):2113-22. doi: 10.1200/JCO.2005.02.8035. J Clin Oncol. 2006. PMID: 16648513 Review.

6

The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.

Peintinger F, Symmans WF, Gonzalez-Angulo AM, Boughey JC, Buzdar AU, Yu TK, Hunt KK, Singletary SE, Babiera GV, Lucci A, Meric-Bernstam F, Kuerer HM. Peintinger F, et al. Cancer. 2006 Sep 15;107(6):1248-54. doi: 10.1002/cncr.22111. Cancer. 2006. PMID: 16862596 Free article.

7

Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.

McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SW, Yu TK, Strom EA, Oh JL, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin AA, Hortobagyi GN, Buchholz TA. McGuire SE, et al. Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1004-9. doi: 10.1016/j.ijrobp.2007.01.023. Epub 2007 Apr 6. Int J Radiat Oncol Biol Phys. 2007. PMID: 17418973 Free PMC article.

8

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.

Mazouni C, Peintinger F, Wan-Kau S, Andre F, Gonzalez-Angulo AM, Symmans WF, Meric-Bernstam F, Valero V, Hortobagyi GN, Pusztai L. Mazouni C, et al. J Clin Oncol. 2007 Jul 1;25(19):2650-5. doi: 10.1200/JCO.2006.08.2271. J Clin Oncol. 2007. PMID: 17602071

9

Trends for inflammatory breast cancer: is survival improving?

Gonzalez-Angulo AM, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, Buchholz TA, Sahin A, Singletary SE, Buzdar AU, Hortobágyi GN. Gonzalez-Angulo AM, et al. Oncologist. 2007 Aug;12(8):904-12. doi: 10.1634/theoncologist.12-8-904. Oncologist. 2007. PMID: 17766649 Free article.

10

Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.

Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Jeruss JS, et al. J Clin Oncol. 2008 Jan 10;26(2):246-52. doi: 10.1200/JCO.2007.11.5352. Epub 2007 Dec 3. J Clin Oncol. 2008. PMID: 18056680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page